- Home
- NTCL vs KRRO Comparison
NTCL vs KRRO Comparison
Compare NTCL & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTCL
- KRRO
- Stock Information
- Founded
- NTCL 2003
- KRRO 2014
- Country
- NTCL China
- KRRO United States
- Employees
- NTCL N/A
- KRRO N/A
- Industry
- NTCL
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- NTCL
- KRRO Health Care
- Exchange
- NTCL NYSE
- KRRO Nasdaq
- Market Cap
- NTCL 193.8M
- KRRO 209.6M
- IPO Year
- NTCL 2024
- KRRO 2019
- Fundamental
- Price
- NTCL $28.30
- KRRO $15.56
- Analyst Decision
- NTCL
- KRRO Strong Buy
- Analyst Count
- NTCL 0
- KRRO 7
- Target Price
- NTCL N/A
- KRRO $90.67
- AVG Volume (30 Days)
- NTCL 765.5K
- KRRO 103.1K
- Earning Date
- NTCL 01-01-0001
- KRRO 05-07-2025
- Dividend Yield
- NTCL N/A
- KRRO N/A
- EPS Growth
- NTCL N/A
- KRRO N/A
- EPS
- NTCL N/A
- KRRO N/A
- Revenue
- NTCL $10,101,647.00
- KRRO $4,821,000.00
- Revenue This Year
- NTCL N/A
- KRRO N/A
- Revenue Next Year
- NTCL N/A
- KRRO $55.56
- P/E Ratio
- NTCL N/A
- KRRO N/A
- Revenue Growth
- NTCL N/A
- KRRO N/A
- 52 Week Low
- NTCL $4.59
- KRRO $11.13
- 52 Week High
- NTCL $51.80
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- NTCL N/A
- KRRO 45.62
- Support Level
- NTCL N/A
- KRRO $13.40
- Resistance Level
- NTCL N/A
- KRRO $22.15
- Average True Range (ATR)
- NTCL 0.00
- KRRO 2.47
- MACD
- NTCL 0.00
- KRRO 0.07
- Stochastic Oscillator
- NTCL 0.00
- KRRO 24.69
About NTCL NETCLASS TECHNOLOGY INC
Netclass Technology Inc is a business-to-business smart education specialist, providing IT solutions to schools, training institutions, corporations, public agencies and other institutions or corporate customers. It offers SaaS subscription service and application development. The solution's modules include teaching management, campus management, online teaching, online examination, epidemic prevention and control, education credit blockchain system, and lecturer evaluation services.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.